Sunil Mistry
Clinical Research Lead at Compass Pathways
Papers
7 publications
Trials
0 clinical trials
Key Impact
He is an author on multiple Compass Pathways psilocybin studies spanning healthy-volunteer, depression, SSRI-concomitant, and follow-up research.
Background & Research
Sunil Mistry appears to be a clinical research professional associated with Compass Pathways, contributing to the company’s psilocybin clinical program. He is listed as an author on several papers covering treatment-resistant depression, antidepressant discontinuation, long-term follow-up, and a healthy-participant phase 1 trial.
Collaboration Network
26 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersTreatment-Resistant Depression (TRD)Anxiety DisordersSuicidalitySafety & Risk ManagementMajor Depressive Disorder (MDD)Healthy VolunteersSet & SettingPersonality DisordersHeadache Disorders (Cluster & Migraine)Chronic PainObsessive-Compulsive Disorder (OCD)Substance Use Disorders (SUD)Palliative & End-of-Life DistressInterpersonal Functioning & Social ConnectednessNeuroimaging & Brain Measures